Narrow search
Showing 1 - 10 of 305
Cover Image
Consequences of the TRIPS-Agreement for the provision of pharmaceuticals in developing countries
Oppermann, Julia - 2008
spreading of HIV/AIDS in developing countries combined with a high price level of patented pharmaceuticals used for the … Arzneimittel zur Behandlung dieser Krankheit. Zum anderen wurde auch der Mangel wirksamer Medikamente gegen vernachlässigte … Immatrialgüterrechte wesentliche Vorraussetzung für die konstante Entwicklung innovativer Arzneimittel seien. Kritiker des TRIPS …
Persistent link: https://www.econbiz.de/10009475357
Cover Image
Markteintritt deutscher KMU in Japan ? eine theoretische und empirische Analyse anhand der Medizintechnikindustrie
Toto, Serkan - 2009
small and medium-sized companies are being taken into account. The transaction cost theory serves as the theoretical …
Persistent link: https://www.econbiz.de/10009485594
Cover Image
The pricing journey – the evolution of approach and execution as organisational pricing capability develops
Ford, M; Dennis, C - 2010
An organisation’s approach to Pricing can be seen as a competency in the sense that it is a combination of skills, behaviours and the application of knowledge. As the efficiency and effectiveness of pricing decisions improve, then a range of indicators highlight a more thorough, considered and...
Persistent link: https://www.econbiz.de/10009465554
Cover Image
Auswirkungen von Medikamentengenehmigungen auf die Bewertung von Biotech- und Pharmaunternehmen: Eine Ereignisstudie. Eine empirische Untersuchung
Sturm, Andreas - 2006
Die Arbeit untersucht den Einfluss der Genehmigung von Medikamenten durch die amerikanische Zulassungsbehörde FDA (Food and Drug Administration) auf den Aktienkurs der Antrag stellenden Aktiengesellschaft. Dabei werden Genehmigungen von wichtigen pharmazeutischen und biopharmazeutischen...
Persistent link: https://www.econbiz.de/10009450191
Cover Image
Change agents and the evolution of the United States pharmaceutical industry, 1920--1960
Lee, Jeho - 1996
dominated the market in the two decades following 1960. In sum, this study corroborates the central part of evolutionary theory …
Persistent link: https://www.econbiz.de/10009439017
Cover Image
Canada-India firm collaboration in health biotechnology
Ray, Monali; Thorsteinsdóttir, Halla - 2008
Strategic alliances are of critical importance to firms working in the health biotechnology2 field. Collaborations can provide firms with significant competitive advantages, shape their economic performance and help minimize risks in development activities (Hagedoorn, 1993). Alliances in the...
Persistent link: https://www.econbiz.de/10009475749
Cover Image
Human resource management and learning based on in-house R&D in a developing country context
Santiago, Fernando; Alcorta, Ludovico - 2009
This paper investigates the influence of human resource management practices on the likelihood that a firm performs in-house R&D. The latter is broadly interpreted as learning---a mechanism promoting absorptive capacity and supporting technology capability-building in latecomer firms. The use of...
Persistent link: https://www.econbiz.de/10009476008
Cover Image
Intellectual Property Rights Regime and Creation of Innovation Based Enterprises in India
Basant, Rakesh - 2006
pharmaceuticals- biotechnologysectors. It is built on the premise that ceteris paribus participation of Indian firms in IPcreation and …
Persistent link: https://www.econbiz.de/10009476130
Cover Image
Farmacijos pramonės etinės problemos
Broga, Mindaugas - 2010
Šiame darbe stengiamasi išanalizuoti farmacijos pramonės etines problemas ir pateikti galimus šių problemų sprendimo būdus bei ateities perspektyvas. Farmacijos produktų specifika nulemia farmacijos kompanijų moralinių ir socialinių pareigų visumą ir įpareigoja kompanijas ne tik...
Persistent link: https://www.econbiz.de/10009479276
Cover Image
Empirical Essays in Health Economics
Garthwaite, Craig Loren - 2009
Chapter 1: The Economic Effects of Medical Innovations: Vioxx and Labor SupplyDespite dramatic improvements in medical technology over time, comparatively little attention has been paid to the effect of these innovations on economic outcomes. This study uses seven overlapping panels of the...
Persistent link: https://www.econbiz.de/10009450754